Breast Infections With Mycobacterium goodii After Reduction Mammaplasty

Abstract

Mycobacterium goodii was identified in 1999 as a rapidly growing nontuberculous mycobacteria species related to the Mycobacterium smegmatis group isolated from human wound infections. Infection with this organism is exceptionally rare after breast surgery in the absence of a prosthetic implant.The authors present a case of breast infections with M. goodii after a reduction mammaplasty.

Mycobacterium goodiiinfection associated with bilateral breast tissue expanders

“…Most M. goodii infections associated with surgical implants require the removal of implants and debridement to achieve a clinical cure 4. Most M. goodii isolates are susceptible to trimethoprim/sulfamethoxazole, ciprofloxacin, doxycycline, imipenem and amikacin 7. Although rare, one other M. goodii infection associated with a breast implant was reported in 2017 8.…”

“…Although rare, one other M. goodii infection associated with a breast implant was reported in 2017 8. Additionally, a recent M. goodii infection associated with reduction mammoplasty was reported 7. Due to the rarity of this infection, the optimal treatment regimen, duration and timing of reimplantation of implants are unknown.…”

“…As presentations with this organism are rare, it is unclear what the typical presentation of infected breast expanders is. Reported cases have used at least 3–6 months of combination or monotherapy for deep-seated infections, depending on the situation 5–8…”